The Christie is the largest single site cancer centre in Europe and the first in the UK to be accredited as a comprehensive cancer centre.
In 2024/25, 82% of our patients lived in Greater Manchester, High Peak, or areas of Cheshire. A further 9,100 patients travelled from other areas of the UK.
Gender
51,600 male and female patients (new and follow up) attended at least one outpatient clinic appointment this year. The most common cancers the Trust treats are prostate, breast, haematological and lower gastrointestinal (LGI) cancers. The average age of our patients is 66 years with 40% being over 70 years. In England, in 2020, over half (56%) of all new cancers were diagnosed in people aged 70 years and over, according to NHS England Cancer Registration Statistics.
Female patients
49% of the patients we treat are female, of whom 60% are 60 years or older. The most common cancers we treat for female patients are breast and gynaecological cancers.
Male patients
51% of the patients we treat are male, of whom 70% are 60 years or older. The most common cancers we treat for males are prostate and haematological.
NB: Endocrinology includes patients receiving care for endocrinology related issues as well as endocrine cancers.
Ethnicity
According to the ethnicity figures from the 2021 census and Gov.uk's UK population by ethnicity report, non-white minorities represent 23.6% of the Greater Manchester Population. 64% of our patients record themselves as the ethnicity category "White British" and 5% classify themselves as one of the non-white ethnic minority categories.
The differences between our Christie population and the Greater Manchester population may, at least in part, be due to a lower level of ethnicity data capture for our ethnic minority patents.
Data completeness for ethnicity is 70%
Religion
According to religious demographics from the 2021 census, the largest religious group in Greater Manchester is Christian who account for 47% of the population followed by Muslim, with 13% of the population.
Among our current patients, 41% are Christian and 2% are Muslim, with 10% reporting having no religion. However, there is a significant proportion of patients who have not disclosed their religion.
Sexuality
According to the 2021 census sexual orientation statistics, 3.1% of the UK population (aged 16 years and over) describe themselves as gay, lesbian, bisexual or other sexual orientation. Among our patients less than 1% are recorded as being lesbian, gay or bisexual (LGBTQ). However, there is a significant proportion of patients who have not disclosed their sexuality.
Deprivation
35% of our patients live in the most deprived areas of Greater Manchester. Our measure of deprivation is based on the 2019 Index of Multiple Deprivation (IMD). IMD is the official measure of relative deprivation for small areas in England. The IMD combines information from the 7 domains to produce an overall relative measure of deprivation (see the English Indices of Deprivation 2019 FAQs for more).
Clinical outcomes: 30-day mortality post systemic anti-cancer treatment (SACT)
The Christie has similar 30-day mortality post systemic anti-cancer treatments (SACT) to the national average for all 3 cancer types evaluated (these are prostate, renal and breast). This data is produced by NHS England using data submitted by all NHS providers in England each month. Data is currently only available for 3 cancer types (please note: these evaluations are based on very small numbers of deaths).
Methodology
The patient profile data was produced by the Clinical Outcomes and Data Unit (CODU) at The Christie NHS Foundation Trust. It has been created using data provided by NHS patients who had at least one outpatient clinic appointment at The Christie between April 2024 and March 2025. This includes new patients and those on treatment or follow-up.
Demographic data available here is predominantly generated from the ‘patient registration form’ provided to patients at the point of their first appointment at The Christie. The provision of these data by patients, at the point of registration, is optional. We also receive some data from general practitioners and other providers as part of the patient referral. Some protected characteristics, such as ethnicity, religion, disabilities and sexual orientation, have higher levels of missing data which is a recognized limitation of the information presented here.
The Christie is currently implementing several initiatives to improve the data collection process and engagement with all our patients.
Our gender data reflects the gender patients identify as - we currently don't capture biological sex in our demographic data.
The 30-day mortality post systemic anti-cancer treatment (SACT) data is national data from the NDRS report 30-day mortality post-Systemic Anti-Cancer Therapy - Case-Mix Adjusted Rates - NDRS for patients diagnosed with prostate cancer who received treatment between 2020 and 2022, for patients diagnosed with renal cell carcinoma who received treatment between 2019 and 2022 and for patients diagnosed with breast cancer who received treatment in 2021. Error bars represent 2 standard deviations.